Its happening:https://finance.yahoo.com/news/kazia-therapeutics-licenses-paxalisib-sovargen-125200480.html
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%